Drug Profile
Research programme: skin disorder therapeutics - VivaCell Biotechnology Espana
Alternative Names: CDE 001Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator VivaCell Biotechnology Espana
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atopic dermatitis; Skin and soft tissue infections
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for research development in Skin-and-soft-tissue-infections in Spain (Topical)
- 28 Feb 2020 No recent reports of development identified for research development in Atopic-dermatitis in Spain (Topical)
- 30 Sep 2016 Early research in Skin and soft tissue infections in Spain (Topical)